Navigation Links
Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007
Date:11/20/2007

d to NIS 144 million pro-forma consolidated EBITDA in the third quarter of 2006.

Consolidated Operating Profit for the third quarter totaled NIS 238 million, compared to a pro-forma consolidated operating profit NIS 57 million in the third quarter of 2006.

Operating profit from the Refining segment totaled NIS 180 million, compared to NIS 87 million last year. The lower refining margins contributed to a NIS 61 million decline in operating profit over the second quarter last year, this was completely offset by a NIS 163 million contribution resulting from an increase in quantities sold, changes in the US dollar exchange rate and a decline in operating expenses. The Company's consolidated results in the third quarter last year were negatively affected by the regional hostilities.

Operating profit from the Aromatics segment (conducted through Gadiv Petrochemical Industries Ltd.) totaled NIS 21 million, compared to an operating loss of NIS 11 million in the third quarter last year.

Operating profit from the Polymers segment (conducted through Carmel Olefins) totaled NIS 37 million, compared to an operating loss of NIS 19 million in the third quarter last year.

Consolidated net income for the third quarter of 2007 totaled NIS 178 million, compared to a pro-forma consolidated net income of NIS 24 million in the third quarter last year.

Nine-Month Results

Refining margin for the nine months totaled USD/bbl 8.4 (USD/MT 61.0), compared to the nine months Mediterraneani Ural Cracking Margin average of USD/bbl 5.6 (USD/MT 40.6). Refining margin for the nine months was also substantially higher than the USD/bbl 7.7 (USD/MT 55.9) refining margin in the nine months 2006.

Consolidated EBITDA for the nine months totaled NIS 1,194 million, compared to NIS 973 million pro-forma consolidated EBITDA in the same period last year. Consolidated Operating Profit for the nine months totaled NIS 937 million, compared to a pro-forma consolidated
'/>"/>

SOURCE Oil Refineries Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,...y one to show consistent growth during the U.S. re...remain in trouble, and health systems are coming c... instead of just administrators. , ... employment continued growing in October despite t...
(Date:11/24/2009)...TLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.annou...ntAuthority(OPDA)wererecentlyawarded$2millionbyWas...(CERB)inaprivate/publicpartnershiptoconstructthest...County,WA. ,, "Thisinvestmentwillsignificantlys...eenjobstoLincolnCounty,"saidBlueMarbleEnergyCEOKel...
(Date:11/24/2009)...IEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPharm...thecompanyisscheduledtopresentatthePiperJaffray21s...a.m.EasternTime(8:30a.m.PacificTime)attheNewYorkPa...andChiefExecutiveOfficer,isscheduledtoprovideanove...nddiscoveryprograms. ,, Aliveaudiowebcastofthep...
(Date:11/24/2009)...TLE,Nov.24/PRNewswire-FirstCall/--CellTherapeutics...atthe21stAnnualPiperJaffrayHealthCareConference.Th...PalaceHotel. ,, CTIwillpresentonTuesday,Decembe...udiowebcastofCTI,spresentationwillbeavailableat ww...rreplayafterwards. , ,PiperJaffrayHealthCareConfe...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...ds Product Portoflio with Third FDA Market Clearan..., WAYNE, Pa., Jan. 29 Escalon Medical Corp.,(Nas...510(k) clearance from,the U.S. Food and Drug Admin... Ultrasound System for use with assisted vascular ...nc., plans to commence shipments of,the product in...
...., Jan. 29 Edwards Lifesciences,Corporation (NYSE...ies to,treat advanced cardiovascular disease, plan...r ended December 31, 2007 after the market closes ...rence call at 5:00 p.m. ET,that day to discuss its... dial (877) 407-8037 or (201),689-8037. For 72 hou...
...cement of Convertible Preferred Stock -, DALLAS, ...n Board: ACCP) announced today that it has execute...ompany has entered into agreements,with institutio...ate of,$2.7 million in gross proceeds of the Compa...uity is in addition to the $9.5 million in gross,p...
Other Biology Technology:Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 2Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 3Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access 4Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008 2Access Pharmaceuticals Announces $2.7 Million New Equity 2Access Pharmaceuticals Announces $2.7 Million New Equity 3
(Date:11/23/2009)... day matters to forest trees dealing with drought,...eam led by Professor Malcolm Campbell, University ...ch and colleagues in the department of cell and sy...talizing on their previous work to decode the geno...how poplar trees use their 45,000 genes to respond...
(Date:11/23/2009)...ts gathered this week for the seventh annual Natio...This year,s topic, "Synthetic Biology," brought to...ers to explore the engineering, scientific, and so...hetic biology. , Bonnie L. Bassler, professor of...s year,s conference chair, challenged the attendee...
(Date:11/23/2009)...ncontrovertible evidence" that the volcanic super-...,000 years ago deforested much of central India, s...port. , The volcano ejected an estimated 800 cub...a crater (now the world,s largest volcanic lake) t... Ash from the event has been found in India, the I...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 1Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 2Association of Gaming Equipment Manufacturers 28AGEM 29 Announces 24100 000 in Contributions to Organizations Working to Assist Problem Gamblers 52789 3NASA Extends Bioastronautics Contract With Wyle for Total Value of 24976 Million 13210 1NASA Extends Bioastronautics Contract With Wyle for Total Value of 24976 Million 13210 2Brookdale Announces Second Quarter 2009 Release and Earnings Call 52783 1
...em with antibiotics is that, eventually, bacteria ...ng the gene that confers such resistance, a new dr... University scientists tested the new drug, called...ns of multidrug-resistant Staphylococcus aureus (M... majority of staphylococcal infections worldwide, ...
...N, R.I. July 2, 2008 Standing in a greenhouse at... smiling even though it appeared that something ha...es of grass she planted last February in hundreds ...or of turf science wasn,t surprised. That,s becau...er water for five months, and few varieties of gra...
...ch findings published online in The FASEB Journal... what we eat, our intelligence can improve. Accord...a wide range of foods from infant formula to eggs ...ities. , "I hope human brains will, like those of...atment by making more brain synapses and thus rest...
Other Biology News:New antibiotic beats superbugs at their own game 2Search for salt tolerant grasses aims to improve roadside plantings 2
Alkaline Phosphatase (E. coli C75) from GE Healthcare, formerly Amersham Biosciences
...and cDNA Labeling Kit with CyScribe GFX Purificati...ication of Cy3- and Cy5-labeled cDNA.Optimized rea...ling and purification.Flexible and optimized proto... with either Cy3- or Cy5-labeled nucleotides.Relia...
...ling Kit with CyScribe GFX Purification Kit, 24 re...3- and Cy5-labeled cDNA.Optimized reagents are pac...fication.Flexible and optimized protocols can be u...Cy3- or Cy5-labeled nucleotides.Reliable purificat...
Canine serum from Equitech-Bio
Biology Products: